← Back to headlines
Stifel and Jefferies Raise Price Targets for Tango Therapeutics Stock
Investment firms Stifel and Jefferies have both raised their price targets for Tango Therapeutics (TNGX) stock, signaling positive outlooks for the company.
6 Apr, 21:10 — 6 Apr, 21:10
Sources
Showing 1 of 1 sources
